Metabolomics as a tool to predict the risk of decompensation or liver-related death in patients with compensated cirrhosis.
Nicoară-Farcău O, Lozano JJ, Alonso C, Sidorova J, Villanueva C, Albillos A, Genescà J, Llop E, Calleja JL, Aracil C, Bañares R, Morillas R, Poca M, Peñas B, Augustin S, Tantău M, Thompson M, Perez-Campuzano V, Baiges A, Turon F, Hernández-Gea V, Abraldes JG, Tapias EA, Torres F, Bosch J, García-Pagán JC; PreDesCI Study Investigators.
Nicoară-Farcău O, et al. Among authors: villanueva c.
Hepatology. 2023 Jun 1;77(6):2052-2062. doi: 10.1097/HEP.0000000000000316. Epub 2023 Feb 23.
Hepatology. 2023.
PMID: 36811400
Clinical Trial.